Please login to the form below

Not currently logged in
Email:
Password:

Chinese Healthcare

This page shows the latest Chinese Healthcare news and features for those working in and with pharma, biotech and healthcare.

Chinese regulators restrict Baidu healthcare advertising

Chinese regulators restrict Baidu healthcare advertising

Pharma insight on digital marketing, social media, mobile apps, online video, websites and interactive healthcare tools. ... Search engine faces clamp down after death of cancer patient.  . Chinese regulators have told the country's largest search

Latest news

  • Novartis' Japanese subsidiary threatened with suspension Novartis' Japanese subsidiary threatened with suspension

    Meanwhile, in China Novartis indicates it has changed "how we manage meetings with Chinese healthcare organizations and funding for them," whilst introducing "improved financial controls and a review of incentives for

  • Bayer completes takeover of Chinese OTC company Bayer completes takeover of Chinese OTC company

    Expands consumer health presence with Dihon purchase. Germany's Bayer has completed its acquisition of the China-based consumer healthcare company Dihon Pharmaceutical. ... The Dihon deal is valued at considerably less – just 460m – but gives Bayer a

  • The M&A trend in pharma The M&A trend in pharma

    and the Chinese government's rising investment in healthcare (including a major healthcare reform to extend insurance provision to rural areas) will all drive increased demand for certain products (especially when ... 2014 has also seen increased M&A

  • Actavis divests another Chinese interest Actavis divests another Chinese interest

    The new comes hard on the heels of comments by Actavis chief executive Paul Bisaro told the Bloomberg news agency at the JPMorgan healthcare conference that the Chinese market has become ... manufacturing and marketing capabilities allowing them to

  • Sanofi and Lilly also visited by Chinese authorities Sanofi and Lilly also visited by Chinese authorities

    bribery and kickbacks within the Chinese $522bn healthcare system. ... prices for medical equipment such as sutures and staples, in further evidence of a government crackdown on practices in the healthcare sector.

More from news
Approximately 0 fully matching, plus 14 partially matching documents found.

Latest Intelligence

  • Charting a course for expansion Charting a course for expansion

    The move is also an acknowledgement of the way the Chinese healthcare is becoming more dynamic, he said, adding: “We needed to shift in light of that so that's one ... Those discussions help Ipsen progress in putting managed access plans in place

  • Sustainable solutions Sustainable solutions

    This was followed five months later by the smaller, but still notable, deal to acquire the Chinese consumer healthcare company Dihon Pharmaceutical for around $485m. ... Obviously, we can do this only if we find a sustainable way for healthcare systems

  • Unravelling China’s healthcare sector Unravelling China’s healthcare sector

    Healthcare reform. The one-child policy implemented since the 1970s has effectively prevented explosive growth of the Chinese population, but the policymaker then probably did not foresee the challenges faced by ... New leadership. With the new era of

  • China: mapping the territory China: mapping the territory

    Market vigilance is key to success. The 2009 Chinese medical reform heralds large-scale healthcare expansion with wider reimbursement coverage and more affordable medicine. ... Pharmaceutical companies need strategic approaches to engage proactively in

  • Country report: The healthcare market in China Country report: The healthcare market in China

    In 2009, the Chinese government announced an unprecedented healthcare reform plan to support universal healthcare coverage for China's population of 1.3 billion. ... With the ongoing input and commitment of multifunctional key stakeholders, the vision of

More from intelligence
Approximately 0 fully matching, plus 5 partially matching documents found.

Latest from PMHub

  • Webinar: Understanding the Patient Journey in China 2015

    As the affluent middle-class continues to grow and healthcare reforms look set to affect the way that patients access treatment, the Chinese healthcare market is experiencing a period of great ... Register now for the latest in our China webinar

  • Webinar: Understanding the patient journey in China

    As the affluent middle-class continues to grow and healthcare reforms look set to affect the way that patients access treatment, the Chinese healthcare market is experiencing a period of great ... View our latest webinar where, utilising local knowledge

  • Ageing in China: The Implications for Healthcare

    the three core aspects of healthcare that need to be balanced by any healthcare regulator. ... Implications for the healthcare industry. The Chinese government has started to implement major reforms in pharmaceutical policy to control healthcare expenses

  • Webinar: Focus on China: Conducting Research in the World’s Fastest Growing Pharma Market

    This webinar looks to provide market research professionals with an overview of the Chinese healthcare market and provide participants with top tips for conducting relevant and effective market research in the ... region. Watch this webinar now to get an

  • Research Partnership

    The Chinese healthcare market is experiencing a period of great change. ... This webinar looks to provide market research professionals with an overview of the Chinese healthcare market and provide participants with top tips for conducting relevant and

More from PMHub
Approximately 1 fully matching, plus 4 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
M3 (EU)

M3 was founded in 2000 with the goal of changing the world of medicine through making full use of the...

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA
Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad
Six behaviours separate the good brand teams from the bad...

Infographics